tiprankstipranks
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS

Ionis Pharmaceuticals (IONS) Financial Statements

1,261 Followers

Ionis Pharmaceuticals Financial Overview

Ionis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.668; its P/E ratio is -17.92; Ionis Pharmaceuticals is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 119.50M$ 324.50M$ 144.21M$ 110.51M$ 130.52M
Gross Profit$ 117.35M$ 321.44M$ 142.02M$ 415.80M$ -68.63M
EBIT$ -122.17M$ 18.08M$ -136.60M$ -75.16M$ -95.82M
EBITDA$ -116.52M$ 23.69M$ -137.23M$ -75.43M$ -93.77M
Net Income Common Stockholders$ -142.80M$ -9.26M$ 301.03M$ -85.29M$ -124.32M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.21B$ 2.33B$ 2.24B$ 2.39B$ 2.35B
Total Assets$ 2.76B$ 2.99B$ 2.93B$ 2.97B$ 2.89B
Total Debt$ 213.05M$ 257.04M$ 173.04M$ 175.02M$ 185.81M
Net Debt$ -1.99B$ -2.07B$ -2.06B$ -2.21B$ -2.16B
Total Liabilities$ 1.28B$ 2.60B$ 2.62B$ 2.54B$ 2.40B
Stockholders Equity$ 296.51M$ 386.69M$ 315.46M$ 428.30M$ 486.57M
Cash Flow-
Free Cash Flow$ -155.67M$ 32.89M$ -112.26M$ -110.44M$ -145.72M
Operating Cash Flow$ -149.94M$ 32.87M$ -109.02M$ -97.36M$ -133.99M
Investing Cash Flow$ 76.11M$ -26.71M$ 68.71M$ 69.52M$ -325.64M
Financing Cash Flow$ 23.57M$ 40.72M$ -32.27M$ 143.54M$ 492.09M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

Ionis Pharmaceuticals Debt to Assets

Ionis Pharmaceuticals Cash Flow

Ionis Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis